Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28,012 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dendritic Cells: Versatile Players in Renal Transplantation.
Lin J, Wang H, Liu C, Cheng A, Deng Q, Zhu H, Chen J. Lin J, et al. Among authors: zhu h. Front Immunol. 2021 May 19;12:654540. doi: 10.3389/fimmu.2021.654540. eCollection 2021. Front Immunol. 2021. PMID: 34093544 Free PMC article. Review.
[PD-1 expression, mRNA level and cytotoxicity changes in CD19CAR-T cells].
Pu YD, Wang J, Deng Q, Zhu HB, Jiang YY, Meng JX, Li YM. Pu YD, et al. Among authors: zhu hb. Zhonghua Xue Ye Xue Za Zhi. 2019 Sep 14;40(9):759-763. doi: 10.3760/cma.j.issn.0253-2727.2019.09.010. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31648479 Free PMC article. Chinese.
[Analysis of local reactions and efficacy of CD19 chimeric antigen receptor-modified T cells therapy in recurrent/refractory B-cell lymphoma with >7.5 cm lesions].
Li Q, Deng HB, Liu MJ, Lyu CC, Zhu HB, Wang J, Jiang YL, Pu YD, Jiang YY, Li W, Deng Q. Li Q, et al. Among authors: zhu hb. Zhonghua Xue Ye Xue Za Zhi. 2021 Jul 14;42(7):570-576. doi: 10.3760/cma.j.issn.0253-2727.2021.07.007. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 34455744 Free PMC article. Chinese.
[Efficacy and safety of reduced dose of PD-1 inhibitor combined with CD19-CAR-T on B-cell non-Hodgkin lymphoma patients with high expression of PD-1 in peripheral blood].
Wang J, Deng Q, Jiang YY, Zhang R, Zhu HB, Meng JX, Zhao MF, Li YM. Wang J, et al. Among authors: zhu hb. Zhonghua Xue Ye Xue Za Zhi. 2018 Oct 14;39(10):862-865. doi: 10.3760/cma.j.issn.0253-2727.2018.10.015. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 30369210 Free PMC article. Chinese. No abstract available.
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects.
Qian H, Chen Q, Liang L, Zou Y, Pu H, Xin L, Song R, Li T, Zhu H, Wang Y, Tian G, Shen J, Jiang H, Yu C, Wang Z, Jia J. Qian H, et al. Among authors: zhu h. Drug Des Devel Ther. 2021 Jul 6;15:2947-2959. doi: 10.2147/DDDT.S308610. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34262260 Free PMC article. Clinical Trial.
28,012 results
You have reached the last available page of results. Please see the User Guide for more information.